| S. Charles Schulz, MD |
|
Professor and Department Head, Department of Psychiatry University of Minnesota S. Charles Schulz is the Hastings Endowed Chair and Head of the Department of Psychiatry at the University of Minnesota. Dr. Schulz received his medical degree and psychiatric residency training from the University of California, Los Angeles. After his residency he became a clinical associate in the Neuropsychopharmacology section of the National Institute of Mental Health (NIMH).
In 1980, Dr. Schulz moved to the Medical College of Virginia where he started the Schizophrenia Program. His research interests focused on neuropsychiatric studies of teenagers suffering from schizophrenia, including CT research. He worked on the research team that investigated the “low-dose neuroleptic” strategy for borderline personality disorder. In 1983, he became Medical Director of the Schizophrenia Module at the University of Pittsburgh where his research focused on treatment-refractory schizophrenia. In 1986, he moved to the NIMH extramural program where he contributed to the National Plan on Schizophrenia Research. Along with Dr. Carol Tamminga, he started the biennial International Congress on Schizophrenia Research.
Dr. Schulz was Professor and Chairman of the Department of Psychiatry at Case Western Reserve University School of Medicine and University Hospitals from 1989-1999. His research interests included MRI imaging in adolescents with schizophrenia and bipolar illness. He has also been active in clinical trials with antipsychotic medications.
At the University of Minnesota, Dr. Schulz’ work has continued in brain- imaging studies of both schizophrenic and borderline personality disorder patients, as well as in treatment studies. Also, he has been active in planning and executing the FIRST Program with the Mind Research Network.
Dr. Schulz has published over one hundred articles in refereed journals, co-edited six books on schizophrenia, and edited Special Editions of Schizophrenia Bulletin and Psychopharmacology Bulletin. He has received numerous awards including the Kempf Fund Award for Research Development in Psychobiologic Psychiatry from the APA. |